Fujisawa Pharmaceutical Co., Ltd. To Outsource Cefzon Bulk Production To API Corporation
10/19/2005 5:13:07 PM
Tokyo (JCNN) - Fujisawa Pharmaceutical announced on March 23 that the company has agreed with API Corporation on the bulk production of Cefzon, Fujisawa's proprietary oral cepharosporin antibiotic.
Under the terms of the agreement, API will handle production for overseas use and supply Fujisawa with Cefzon bulk.
comments powered by